Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Total Current Liabilities (2016 - 2025)

Alkermes (ALKS) has disclosed Total Current Liabilities for 15 consecutive years, with $543.4 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 16.82% to $543.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $543.4 million through Dec 2025, up 16.82% year-over-year, with the annual reading at $543.4 million for FY2025, 16.82% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $543.4 million at Alkermes, up from $474.4 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $543.4 million in Q4 2025, with the low at $365.8 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $470.3 million, with a median of $470.4 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities increased 26.38% in 2022, then dropped 10.58% in 2024.
  • Over 5 years, Total Current Liabilities stood at $471.3 million in 2021, then grew by 5.61% to $497.7 million in 2022, then rose by 4.52% to $520.2 million in 2023, then dropped by 10.58% to $465.2 million in 2024, then increased by 16.82% to $543.4 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $543.4 million, $474.4 million, and $506.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.